FROM Jill O'Donnell-Tormey
Cancer: Big Business and the Painstaking Search for a Cure Five years ago, cancer researchers were predicting "miracle treatments" — even vaccines -- based on the billions being spent on genetics. But the more they know, the more complicated cancer becomes, and even the American Cancer Society has tempered its optimism. Cancer victims, and members of Congress, are increasingly impatient with the slow pace of improvement. Are financial conflicts part of the problem? Given what’s known about personal habits like smoking, about occupational hazards and the environment, should more be spent on prevention?
Human Rights in the era of Donald Trump President Trump’s UN Ambassador, Nikki Haley, said today the US might pull out of the United Nations’ Human Rights Council. Serious violators of human rights are members of the Council itself–and a US resignation could make things worse. Later on today’s show, now that he’s into his second term, comedian turned US Senator Al Franken is telling jokes again.
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.